Insight Pharmaceuticals LLC has announced a voluntary recall of one lot of its Nostrilla Nasal Decongestant nasal spray because the product may be contaminated with the respiratory pathogen . Patients who are immunocompromised and those who have underlying pulmonary conditions -- especially cystic fibrosis -- have an increased risk for serious infection if exposed to .
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
Possible Bacterial Contamination Spurs Nasal Spray Recall
- Login or register to post comments
- Feed: Health of the Public
- Original article